Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Abbott
MedTech
Abbott snags US approval for mitral valve replacement implant
The FDA approved Abbott's Tendyne minimally invasive heart replacement for mitral valve disease that could disqualify patients for other approaches.
Conor Hale
May 27, 2025 10:30am
Abbott’s rapid blood-based concussion test is off to the races
May 6, 2025 10:00am
Next-gen pulsed field ablation comes to the fore at HRS
Apr 27, 2025 1:15pm
Abbott aims to weather tariffs by investing in US manufacturing
Apr 16, 2025 11:45am
Abbott secures European approval for Volt pulsed field ablation
Mar 27, 2025 3:45pm
Abbott launches coronary intravascular lithotripsy trial
Mar 24, 2025 11:35am
